September's issue of Kidney international (KI) will feature an important article from Ziyad Al-Aly and colleagues, which uses Global Burden of Disease (GBD) data to show, in just one generation since 1990, an almost doubling of the incidence, prevalence and mortality of chronic kidney disease (CKD), and a more than 60% increase in disability-adjusted...
The 2017 impact factors have now been published. Find out more about how our publications have been rated! Kidney International’s (KI) 2017 Impact Factor has increased to 8.429 (a small increase over the 2016 IF of 8.395). Kidney International Supplements 2017 Impact Factor is 3.357 (a decrease from the 2016 IF of 5.593). KI ranks now...
Following March's second Global Kidney Health Summit in the United Arab Emirates, the outputs from this meeting are currently being written for publication. In the meantime, here is what came out the first Global Kidney Health Summit held in Canada in 2016. During the first ISN Global Kidney Health Summit, a selected group of 85 international key...
We sat down with Pierre Ronco to discover what lies ahead for one of nephrology’s leading journals and hear about his plans to respond to the challenges of publishing and education within the field. What do you enjoy the most about heading such a high-ranking journal? Pierre Ronco: ‘It is a privilege and a huge responsibility. Fortunately,...
The purpose of the Brief Report format is to publish concise but complete reports that present high-quality findings of exceptional interest, novelty, and broad significance for the readers of Kidney International. Manuscript considered as a potential Brief Report by the Editors will be sent to referees with a request of rapid review. If the manuscript...
We are excited to announce that Kidney International (KI) Reports has now been fully accepted and is live in PubMed Central (PMC). PMC indexed back to Volume 1, Issue 1 and there are 177 article records at present. We will feed new articles as they are published directly to PMC for indexing. KI Reports article records can...
As part of the end-stage kidney disease (ESKD) focus, the ISN Ethical Dialysis Taskforce will publish reviews and position statements on ethical dialysis over the next few years. We already developed a first series of papers on ethical dialysis published in The Lancet. This will be relevant to emerging and developed countries. As a global society with...
Acute kidney injury (AKI) is an increasingly significant yet underdiagnosed problem in pediatric care. In this latest Lancet update, colleagues from the International Pediatric Nephrology Association delve into international efforts to address this inequity, and what’s required from the World Health Organization and nephrology community to fulfil the 0by25 mission of zero preventable deaths from...
One of this month’s most downloaded reports from Kidney International (KI) Reports is contributed by Fabiana Nerbass, winner of the ISN-H4KH New Investigator grant. This publication was made possible with valuable support from the ISN-H4KH New Investigator grant in partnership with Danone Nutricia. Fabiana Nerbass was awarded the funding in 2015. Her research on “Occupational Heat Stress...
Between 2.3 and 7.1 million people die annually from End-Stage Kidney Disease (ESKD) due to a lack of access to dialysis. As a high-income country with expertise in peritoneal dialysis (PD), Hong Kong has a lot of practical experience to offer its neighboring low- and middle-income countries in tackling this growing issue. I highlighted the...
The Kidney International (KI) mobile app is now available to download for free on Apple and Google Play. The app includes access to all three ISN journals: KI, Supplements, and Reports. Tables of contents and article abstracts for the three journals are available for members to read as well as full-text articles for KI Reports...
This recent commentary featured in The Lancet Diabetes Endocrinal 2017 focuses on the need for coordinated efforts and a large international database of patients with diabetes and nephropathy. It refers to ISN and its Advancing Clinical Trials group and Clinical Trial Networks who could be instrumental in achieving this objective. Read more HERE.
According to the recent Google Scholar metrics, Kidney International is ranked first among all nephrology journals. Google Scholar Metrics provide an easy way for authors to quickly gauge the visibility and influence of recent articles in scholarly publications. Scholar Metrics summarize recent citations to many publications, to help authors as they consider where to publish their...
The 2016 Impact Factor information for Kidney International (KI) and KI Supplements has now been released. The KI 2016 Impact Factor is 8.395 (an increase from the 2015 IF of 7.683). The Kidney International Supplements 2016 Impact Factor is 5.593 (a decrease from the 2015 IF of 7.026). The increase in the KI 2016 Impact...
Every month, the ISN-Advancing Clinical Trials (ACT) will share a 'must-read trials list’ highlighting and sometimes analyzing important nephrology trials from the latest medical literature. The inaugural May edition is now available on ISN Academy. Get more information, HERE.
Get your latest editions of Kidney International and Seminars in Nephrology Make use of access to the ISN Academy to read the latest edition of Kidney International. Check out the latest from Seminars in Nephrology. Read the May 2017 Issue of Kidney International on ISN Academy. Our flagship journal informs the renal researcher and the...
The road map stemming from discussions that took place at last year’s first ISN Summit focusing on chronic kidney disease have now been published in The Lancet Health Review. The global nephrology community recognises the need for a cohesive plan to address the problem of chronic kidney disease (CKD). In July, 2016, ISN hosted a...
Our own epidemiological research, and that of others in Sub-Sahara Africa (SSA), demonstrates that the majority of Acute Kidney Injury (AKI) seen at tertiary centers is severe (i.e. Stage 3 AKI). This suggests there is often a delay in AKI diagnosis after disease onset. Access to laboratory estimates of renal function (i.e serum urea or...
The latest Lancet Kidney Campaign update focuses on cancer and kidney disease. The second and ninth leading causes of death in patients in the United States, respectively. In this month’s Lancet Kidney Campaign update, Mark Perazella from Yale University tells us about the unique connection between these two maladies, and how it gave rise to...
The American Society of Nephrology commemorated its 50th anniversary with a memorable ASN Kidney Week in Chicago in November 2016. Professors Rumeyza Kazancioglu (Turkey) and Roberto Pecoits-Filho (Brazil) draw from their different world perspectives to identify and break down the main highlights from this congress that focused on "Reinventing Nephrology: From Molecule to Man." CLICK HERE to...
